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Otosclerosis due to abnormal bone homeostasis of the otic capsule is a frequent cause of hearing loss in adults.
Usually, the hearing loss is conductive, resulting from fixation of the stapedial footplate, which prevents normal
ossicular vibration in response to sound. An additional type of sensorineural hearing loss may be caused by
otosclerotic damage to the cochlea. The etiology of the disease is unknown, and both environmental and genetic
factors have been implicated. Autosomal dominant inheritance with reduced penetrance has been proposed, but
large families are extremely rare. To elucidate the pathogenesis of the disease, identification of the responsible genes
is essential. In this study, we completed linkage analysis in a Belgian family in which otosclerosis segregates as an
autosomal dominant disease. After excluding linkage to a known locus on chromosome 15 (OTSC1), we found
linkage on chromosome 7q, with a multipoint LOD score of 3.54. Analysis of key recombinant individuals maps
this otosclerosis locus (OTSC2) to a 16-cM interval on chromosome 7q34-36 between markers D7S495 and
D7S2426.
Hearing impairment is one of the most frequent handi-
caps in the Western world. It can be conductive (caused
by abnormalities in the conduction of sound in the outer
or middle ear) or sensorineural (resulting from defects
in the perception of sound in the inner ear) or both
(mixed). Otosclerosis is a common bone disorder of the
otic capsule, unique to the endochondral layer of the
temporal bone and known to affect human beings only
(Declau and Van de Heyning 1996). Otosclerosis leads
to a progressive hearing impairment characterized by
conductive or mixed hearing loss. The conductive hear-
ing loss is due to a fixation of the stapedial footplate in
the oval window, and cochlear otosclerotic foci are
thought to cause a sensorineural component in some
cases. Although stapedial microsurgery has proved to be
a successful means of reducing the conductive hearing
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impairment, otosclerosis gives rise to considerable mor-
bidity (Somers et al. 1997).
Otosclerosis is divided into histological and clinical
types. The term “histological otosclerosis” is used to
describe otosclerosis in the absence of clinical symptoms
or manifestations. This type of disease, which is discov-
ered by routine sectioning of temporal bones at autopsy,
has a prevalence of 6%–7% (Morrison and Bundey
1970). Clinical otosclerosis (MIM 166800), in contrast,
implies the presence of hearing impairment (Shambaugh
1949). Its prevalence is 0.2%–1% among white adults,
and the age at onset is usually 20–40 years (Gordon
1989). In ∼85% of patients, both ears are involved
(Somers et al. 1994).
The etiology of otosclerosis is complex, and it prob-
ably involves an interaction between genes and environ-
mental factors. Epidemiological studies support auto-
somal dominant inheritance with reduced penetrance
(Albrecht 1922; Larsson 1962; Morrison 1967; Causse
and Causse 1984; Ben Arab et al. 1993), although a
viral involvement also has been suggested (Niedermeyer
et al. 1994; Arnold et al. 1996; McKenna et al. 1996).
Because the etiology of otosclerosis remains poorly char-
acterized, no effective medical therapy has been devel-
Figure 1 Pedigree of the Belgian family with autosomal dominant otosclerosis, showing the most likely haplotypes for the chromosome 7 markers. The haplotype linked to otosclerosis is boxed.
Only family members whose DNA was analyzed are numbered. A question mark (?) inidicates family members with an atypical or limited hearing impairment; an asterisk (*) indicates persons with
surgically confirmed otosclerosis; and an exclamation point (!) indicates the phenocopy (person III-19).
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Table 1
Comparison of Markers for Chromosome 15q25-26 and the Known
Otosclerosis Locus (OTSC1)
MARKER
TWO-POINT LOD SCORES AT v p
.0 .01 .05 .1 .2 .3 .4
D15S652 -3.54 3.16 2.65 2.18 1.12 .48 .14
D15S1004 5.08 3.83 2.35 1.56 .72 .27 .06
D15S657 4.52 3.50 1.94 1.17 .51 .20 .05
Table 2
Comparison of Markers for Otosclerosis and Chromosome 7
(OTSC2)
MARKER
TWO-POINT LOD SCORES At v p
.0 .01 .05 .1 .2 .3 .4
D7S509 .54 .06 .59 .76 .64 .35 .1
D7S495 .26 .02 .44 .57 .48 .27 .09
D7S2560 1.21 1.18 1.07 .94 .68 .44 .22
D7S684 1.52 1.72 1.88 1.76 1.29 .74 .27
D7S2505 1.15 1.35 1.53 1.44 1.03 .56 .16
D7S2513 1.29 1.49 1.64 1.52 1.02 .45 .05
D7S2426 .11 .60 1.26 1.44 1.28 .83 .27
D7S1826 .15 .52 1.07 1.25 1.14 .77 .30
oped to prevent or stabilize the disease. Large families
of 10 affected persons are difficult to ascertain, and
other factors, such as reduced penetrance and a high
frequency of phenocopies, complicate efforts at linkage
analysis. At present, only one locus for otosclerosis,
OTSC1 on chromosome 15q25-26, has been identified,
and the responsible gene has not been cloned (Tomek et
al. 1998). Otosclerosis is therefore one of the last im-
portant types of hearing impairment for which a genetic
cause remains to be elucidated.
The Belgian family presented here (fig. 1) displays au-
tosomal dominant otosclerosis and was ascertained
through the Saint-Augustinus Hospital. We performed
pure-tone audiometry for all family members, using air
conduction at 250, 500, 1000, 2000, 4000, and 8000
Hz and bone conduction at 500, 1000, 2000, and 4000
Hz. Ten persons with surgically confirmed otosclerosis
were considered affected. For the patients who had not
had surgery, the clinical diagnosis of otosclerosis was
based on audiological data, which we analyzed using an
algorithm described elsewhere (Govaerts et al. 1998). In
brief, the audiometric curves of these persons were com-
pared with age- and sex-dependent data according to
the International Organization for Standardization 7029
standard (1984). Using analysis of variance, we deter-
mined the frequency that was the most sensitive indi-
cator of otosclerosis in this family, and we ranked family
members according to their hearing loss, expressed as
hearing standard deviations (HSD) at this frequency.
In addition, we measured tympanic membrane compli-
ance and ipsilateral and contralateral stapedial reflex
decay. Seven additional persons, who had a conductive
or mixed hearing loss that exceeded three HSDs together
with absent or immeasurable stapedial reflexes, were
classified as affected. Because the age at onset of oto-
sclerotic hearing loss varies, only family members who
were 160 years of age and had normal hearing (!2
HSDs) were considered unaffected. Only one family
member (1.7 HSDs at age 70 years) and three relatives
by marriage were labeled unaffected. The status of the
remaining four persons was considered uncertain. In-
formation on deceased the deceased was obtained by
questioning living family members.
After the 25 participants gave informed consent,
blood samples were obtained and were used as a source
of genomic DNA, which was isolated by standard tech-
niques. All these 25 DNA samples (from familymembers
numbered in fig. 1) were used in subsequent LOD score
calculations. LOD scores were calculated using the
FASTLINK computer program (Cottingham et al. 1993).
The linkage parameters were chosen in compliance with
the body of older studies (Larsson 1960;Morrison 1967;
Gapany-Gapanaviscius 1975; Donnell and Alfi 1980;
Causse and Causse 1984), which suggest that otoscle-
rosis is inherited as an autosomal dominant disease with
reduced penetrance. As standard linkage parameters, the
frequency of the otosclerosis gene was set at .0001, and
the disease was assumed to be autosomal dominant and
90% penetrant. To allow for possible phenocopies, this
chance was set at 1%, because without surgical explo-
ration it is often difficult to exclude hearing impairment
of other origins. Equal recombination frequencies be-
tween males and females were assumed. For each
marker, the number of alleles in the LOD score calcu-
lations was set at the observed number of alleles in the
pedigree (N); allele frequencies were set at 1/N.
First, linkage to the known otosclerosis locus on chro-
mosome 15q25-q26 was investigated using the linked
markers D15S652, D15S1004, and D15S657 (Tomek et
al. 1998). This locus was excluded with negative two-
point LOD scores (table 1). A genome search was then
performed on 25 DNA samples, using genetic markers
from the Cooperative Human Linkage Center screening
set (Weber, version 6). This set contains 391 microsat-
ellite markers covering the complete genome, with an
average intermarker spacing of 10 cM and an average
heterozygosity of 76%. Because we did not detect link-
age with these markers, we screened another 66 markers
from a second genomewide microsatellite set for fluo-
rescence-based, semiautomated genome mapping (Reed
et al. 1994) and 120 markers from the Ge´ne´thon genetic
linkage map (Dib et al. 1996). Although this second
analysis did not generate a two-point LOD score 13,
there were five regions with a positive two-point LOD
score 11. At this time, 75% of the complete genome had
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Figure 2 Localization of OTSC2 on chromosome 7q34-36. The
black bar indicates the region on the Ge´ne´thon genetic map (Dib et
al. 1996) that contains the gene for otosclerosis. The distances between
the markers are represented in centimorgans.
Table 3










90 1 1/1,000 3.50
90 1 1/10,000 3.54
90 1 1/100,000 3.54
90 .2 1/10,000 3.44
90 5 1/10,000 3.65
40 1 1/10,000 3.39
been excluded, with negative two-point LOD scores
!2; two-point LOD scores !1 were reached for 92%
of the genome.
The five candidate regions were examined using ad-
ditional markers to reconstruct haplotypes. Four of the
regions with two-point LOD scores 11 were excluded,
but one region was also positive when tested with ad-
ditional markers. This region on chromosome 7 includes
marker D7S684, which gave a two-point LOD score of
1.88 at recombination fraction (v) .05 (table 2). In the
D7S2560–D7S2513 interval, multipoint calculations
were performed using five-point rolling LODs. A max-
imum multipoint LOD score of 3.54 was obtained when
standard linkage parameters were used. When the dis-
ease gene frequency was varied, the penetrance and the
phenocopy rate had little effect on the LOD score results
(table 3), showing that the LOD score calculations were
robust to changes in linkage parameters. An eight-
marker haplotype was constructed (fig. 1). Flanking
markers were defined by recombinations in individuals
III-11 (D7S2426, telomeric) and III-16 (D7S495, cen-
tromeric). A genetic map of the candidate region is pre-
sented in figure 2. The key recombinant individuals place
the gene for otosclerosis in the 16-cM interval flanked
by markers D7S495 and D7S2426.
Although subject III-19 received the clinical diagnosis
of otosclerosis on the basis of audiometric testing, she
did not inherit the disease haplotype, and reevaluation
of the clinical data revealed no obvious discrepancies.
This could reflect an unrecognized double crossover, the
likelihood of which is ∼0.8% between D7S2513 and
D7S2426, ∼0.3% between D7S2505 and D7S2513, and
∼0.07% between D7S495 and D7S684 (the affected
mother of III-19 is not informative at D7S2560). Alter-
natively, because there are numerous causes of acquired
conductive or mixed hearing loss, the finding could re-
flect a phenocopy. For example, incudo-malleolar fixa-
tion and tympanosclerosis can result in identical audi-
ometric profiles, and distinguishing these etiologies from
otosclerosis requires surgical exploration of the middle
ear.
The OTSC2 interval includes several known genes,
one of which (TIF1a [MIM 603406]), is a growth sup-
pressor required for the growth-inhibitory activity of re-
tinoic acid (RA). Studies have shown that all-trans RA
disrupts differentiation and development of the otic cap-
sule. This teratogen produces malformations of the epi-
thelium-derived auditory and vestibular receptors of the
inner ear and its surrounding cartilaginous capsule
(Frenz and Liu 1997). PLOD3 (procollagen-lysine, 2-
oxyglutarate, 5-dioxygenase 3 [MIM 603066]) also
maps to the candidate region. This gene plays an im-
portant role in collagen biosynthesis and metabolism, an
intriguing function in view of the pathological charac-
teristics of otosclerosis. In vitro expression studies have
shown that PLOD3 hydroxylates lysyl residues in col-
lagen sequences in non-triple-helical conformation (Val-
tavaara et al. 1998). This activity is enhanced by tumor
necrosis factor–a (TNFa), an important mediator in the
pathogenesis of arthritis, resulting in the degradation of
cartilage and the destruction of joints (Ah-Kim et al.
2000). Therefore, PLOD3 may play a role in affect-
ing cartilage homeostasis of the inner and middle ear by
interfering with chondrocytic responses to TNFa-
mediated stimuli.
Cloning and completing functional and structural
analysis of the OTSC2 gene may provide new insights
into the molecular mechanisms of otosclerosis and may
reveal targets for prevention and treatment of the dis-
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ease. However, the realization of these aims will depend,
in part, on the degree of heterogeneity among affected
persons. In the only two completed linkage studies, two
distinct loci have been identified. In both instances, the
defined candidate regions are large, and it is possible
that the relevant genes will not be identified until ad-
ditional families are ascertained and studied.
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